GuangYuYuan Chinese Herbal Medicine Co., Ltd. (SHA:600771)
China flag China · Delayed Price · Currency is CNY
11.92
-0.28 (-2.30%)
Nov 18, 2026, 3:00 PM CST

SHA:600771 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
1,3101,3681,2201,2831,116849.3
Other Revenue
1.521.521.211.3414.534.93
1,3121,3691,2211,2841,131854.22
Revenue Growth
-5.53%12.11%-4.88%13.56%32.37%-23.00%
Cost of Revenue
447450.09329.93350.72404.77333.11
Gross Profit
864.77919.21891.49933.3725.95521.11
Selling, General & Admin
718.51728.8665.54736.08881.9867.33
Research & Development
36.5838.4738.5931.3828.9625.19
Other Operating Expenses
24.2329.6526.6127.919.5717.46
Operating Expenses
777.08796.82800.75820.11952.63883.95
Operating Income
87.7122.3990.74113.18-226.68-362.84
Interest Expense
-1.96-2.52-6.43-16.94-20.95-19.09
Interest & Investment Income
0.811.161.772.970.974.94
Earnings From Equity Investments
-----0.92-
Other Non Operating Income (Expenses)
6.52-0.34-0.11-0.41-6.89-10.5
EBT Excluding Unusual Items
93.06120.785.9798.81-254.48-387.48
Gain (Loss) on Sale of Investments
-2.33-2.26-7.73---4.22
Gain (Loss) on Sale of Assets
---0.020.19-0.020.37
Asset Writedown
-19.07-18.91-4.71-0.02-19.89-
Other Unusual Items
3.53.517.331.399.2538.7
Pretax Income
75.16103.0480.85100.37-265.13-352.63
Income Tax Expense
10.539.35-2.757.52-2.13-20.2
Earnings From Continuing Operations
64.6663.6983.692.85-263.01-332.43
Minority Interest in Earnings
-1.43-0.65-9.15-2.7712.9816.19
Net Income
63.2263.0474.4590.08-250.02-316.24
Net Income to Common
63.2263.0474.4590.08-250.02-316.24
Net Income Growth
-23.25%-15.32%-17.35%---
Shares Outstanding (Basic)
486485496500490494
Shares Outstanding (Diluted)
571485573500490494
Shares Change
1.60%-15.32%14.44%2.08%-0.79%8.08%
EPS (Basic)
0.130.130.150.18-0.51-0.64
EPS (Diluted)
0.110.130.130.18-0.51-0.64
EPS Growth
-24.46%0%-27.78%---

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
215.32191.65103.61212.99244.7663.17
Free Cash Flow Per Share
0.380.400.180.430.500.13
Gross Margin
65.92%67.13%72.99%72.69%64.20%61.00%
Operating Margin
6.69%8.94%7.43%8.82%-20.05%-42.48%
Profit Margin
4.82%4.60%6.10%7.02%-22.11%-37.02%
Free Cash Flow Margin
16.41%14.00%8.48%16.59%21.65%7.40%
EBITDA
116.27158.07135.88152.46-187.97-324.45
EBITDA Margin
8.86%11.54%11.13%11.87%-16.62%-37.98%
D&A For EBITDA
28.5835.6845.1439.2738.7138.39
EBIT
87.7122.3990.74113.18-226.68-362.84
EBIT Margin
6.69%8.94%7.43%8.82%-20.05%-42.48%
Effective Tax Rate
13.97%38.19%-7.50%--
Revenue as Reported
1,3121,3691,2211,2841,131854.22
Advertising Expenses
-27.8719.417.2314.9890.22